17.11 USD
+0.92 (+5.68%)
Taking everything into account, BWAY scores 6 out of 10 in our fundamental rating. BWAY was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While BWAY has a great health rating, its profitability is only average at the moment. BWAY is evaluated to be cheap and growing strongly. This does not happen too often! With these ratings, BWAY could be worth investigating further for value and growth investing!.
1. Profitability
1.1 Basic Checks
BWAY had positive earnings in the past year.
In the past year BWAY had a positive cash flow from operations.
BWAY had negative earnings in 4 of the past 5 years.
In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
BWAY's Return On Assets of 5.53% is amongst the best of the industry. BWAY outperforms 82.35% of its industry peers.
Looking at the Return On Equity, with a value of 8.92%, BWAY belongs to the top of the industry, outperforming 83.42% of the companies in the same industry.
BWAY has a better Return On Invested Capital (2.75%) than 69.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROIC | 2.75% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BWAY's Profit Margin of 12.73% is amongst the best of the industry. BWAY outperforms 89.30% of its industry peers.
Looking at the Operating Margin, with a value of 5.78%, BWAY is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
With an excellent Gross Margin value of 74.92%, BWAY belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
BWAY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BWAY is destroying value.
The number of shares outstanding for BWAY has been increased compared to 1 year ago.
BWAY has more shares outstanding than it did 5 years ago.
BWAY has a worse debt/assets ratio than last year.
2.2 Solvency
BWAY has an Altman-Z score of 4.70. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
BWAY has a Altman-Z score of 4.70. This is in the better half of the industry: BWAY outperforms 77.54% of its industry peers.
BWAY has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.37, BWAY belongs to the top of the industry, outperforming 92.51% of the companies in the same industry.
BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
BWAY has a Debt to Equity ratio of 0.08. This is in the better half of the industry: BWAY outperforms 65.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Altman-Z | 4.7 |
ROIC/WACC0.32
WACC8.56%
2.3 Liquidity
A Current Ratio of 3.19 indicates that BWAY has no problem at all paying its short term obligations.
BWAY has a Current ratio (3.19) which is comparable to the rest of the industry.
BWAY has a Quick Ratio of 3.02. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
BWAY's Quick ratio of 3.02 is fine compared to the rest of the industry. BWAY outperforms 65.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 |
3. Growth
3.1 Past
BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 260.14%, which is quite impressive.
Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 27.08%.
BWAY shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.17% yearly.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
3.2 Future
Based on estimates for the next years, BWAY will show a very strong growth in Earnings Per Share. The EPS will grow by 54.11% on average per year.
The Revenue is expected to grow by 18.80% on average over the next years. This is quite good.
EPS Next Y68.53%
EPS Next 2Y55.05%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.99 indicates a correct valuation of BWAY.
Compared to the rest of the industry, the Price/Earnings ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 86.10% of the companies listed in the same industry.
BWAY is valuated rather cheaply when we compare the Price/Earnings ratio to 26.38, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 12.01 indicates a correct valuation of BWAY.
Based on the Price/Forward Earnings ratio, BWAY is valued cheaply inside the industry as 93.05% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.83. BWAY is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.99 | ||
| Fwd PE | 12.01 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BWAY indicates a rather cheap valuation: BWAY is cheaper than 90.37% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.25 | ||
| EV/EBITDA | 56.81 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BWAY's earnings are expected to grow with 54.11% in the coming years.
PEG (NY)0.23
PEG (5Y)N/A
EPS Next 2Y55.05%
EPS Next 3Y54.11%
5. Dividend
5.1 Amount
BWAY does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:BWAY (12/19/2025, 8:00:02 PM)
17.11
+0.92 (+5.68%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners4.88%
Inst Owner Change-5.42%
Ins Owners16.12%
Ins Owner ChangeN/A
Market Cap334.68M
Revenue(TTM)49.09M
Net Income(TTM)6.25M
Analysts85.71
Price Target0.12 (-99.3%)
Short Float %0.32%
Short Ratio0.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)2.44%
PT rev (3m)5.38%
EPS NQ rev (1m)-6.18%
EPS NQ rev (3m)-22.98%
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-27.48%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.45%
Revenue NY rev (1m)-1.12%
Revenue NY rev (3m)-1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.99 | ||
| Fwd PE | 12.01 | ||
| P/S | 6.82 | ||
| P/FCF | 18.25 | ||
| P/OCF | 15.03 | ||
| P/B | 4.78 | ||
| P/tB | 4.78 | ||
| EV/EBITDA | 56.81 |
EPS(TTM)1.07
EY6.25%
EPS(NY)1.42
Fwd EY8.32%
FCF(TTM)0.94
FCFY5.48%
OCF(TTM)1.14
OCFY6.65%
SpS2.51
BVpS3.58
TBVpS3.58
PEG (NY)0.23
PEG (5Y)N/A
Graham Number9.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROCE | 3.26% | ||
| ROIC | 2.75% | ||
| ROICexc | 15.43% | ||
| ROICexgc | 15.43% | ||
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% | ||
| FCFM | 37.36% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 207.6% | ||
| Cap/Sales | 8.01% | ||
| Interest Coverage | 26.28 | ||
| Cash Conversion | 470.69% | ||
| Profit Quality | 293.55% | ||
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 | ||
| Altman-Z | 4.7 |
F-Score5
WACC8.56%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y68.53%
EPS Next 2Y55.05%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A
BRAINSWAY LTD-ADR / BWAY FAQ
What is the fundamental rating for BWAY stock?
ChartMill assigns a fundamental rating of 6 / 10 to BWAY.
What is the valuation status for BWAY stock?
ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.
How profitable is BRAINSWAY LTD-ADR (BWAY) stock?
BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.
What is the valuation of BRAINSWAY LTD-ADR based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BRAINSWAY LTD-ADR (BWAY) is 15.99 and the Price/Book (PB) ratio is 4.78.